LEDGF.sub.1-326 Decreases P23H and Wild Type Rhodopsin Aggregates and P23H Rhodopsin Mediated Cell Damage in Human Retinal Pigment Epithelial Cells

P23H rhodopsin, a mutant rhodopsin, is known to aggregate and cause retinal degeneration. However, its effects on retinal pigment epithelial (RPE) cells are unknown. The purpose of this study was to determine the effect of P23H rhodopsin in RPE cells and further assess whether LEDGF.sub.1-326, a pro...

Full description

Saved in:
Bibliographic Details
Published in:PloS one Vol. 6; no. 9; p. e24616
Main Authors: Baid, Rinku, Scheinman, Robert I, Shinohara, Toshimichi, Singh, Dhirendra P, Kompella, Uday B
Format: Journal Article
Language:English
Published: Public Library of Science 07-09-2011
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:P23H rhodopsin, a mutant rhodopsin, is known to aggregate and cause retinal degeneration. However, its effects on retinal pigment epithelial (RPE) cells are unknown. The purpose of this study was to determine the effect of P23H rhodopsin in RPE cells and further assess whether LEDGF.sub.1-326, a protein devoid of heat shock elements of LEDGF, a cell survival factor, reduces P23H rhodopsin aggregates and any associated cellular damage. ARPE-19 cells were transiently transfected/cotransfected with pLEDGF.sub.1-326 and/or pWT-Rho (wild type)/pP23H-Rho. Rhodopsin mediated cellular damage and rescue by LEDGF.sub.1-326 was assessed using cell viability, cell proliferation, and confocal microscopy assays. Rhodopsin monomers, oligomers, and their reduction in the presence of LEDGF.sub.1-326 were quantified by western blot analysis. P23H rhodopsin mRNA levels in the presence and absence of LEDGF.sub.1-326 was determined by real time quantitative PCR. P23H rhodopsin as well as WT rhodopsin form aggregates in RPE cells and LEDGF.sub.1-326 decreases these aggregates. Further, LEDGF.sub.1-326 reduces the RPE cell damage caused by P23H rhodopsin. LEDGF.sub.1-326 might be useful in treating cellular damage associated with protein aggregation diseases such as retinitis pigmentosa.
ISSN:1932-6203
1932-6203
DOI:10.1371/journal.pone.0024616